Provision of Assay Kits for SCID Evaluation: EONIS-Q
his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combined Immuno-Deficiency (SCID) in-service evaluation (ISE) in 4 Screening laboratories.
Buyer
NHS England
Value
£949,937
Published
22 Apr 2026
Closes
31 Mar 2025
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Selective
Category
Services
Contract starts
14 Oct 2025
Contract ends
31 Mar 2026
CPV classifications
85100000
Health services
Lots
Lot default Provision of Assay Kits for SCID Evaluation: EONIS-Q
£395,807
his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combined Immuno-Deficiency (SCID) in-service evaluation (ISE) in 4 Screening laboratories.
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
22 Apr 2026
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.